| Jun '21 | Mar '21 | Dec '20 | Sep '20 | Older periods | |
|---|---|---|---|---|---|
| 189.45% | 233.93% | 211.37% | 233.45% |
+8 more TTM periods Free account |
|
| (65.24%) | (64.67%) | (82.81%) | (24.31%) | ||
ROIC |
(169.29%) | (149.73%) | (186.98%) | (15.65%) | |
Return on Tangible Assets |
(166.91%) | (147.25%) | (327.13%) | (36.49%) | |
Average Days of Receivables |
77.65 | 73.01 | 90.68 | 116.55 | |
Free Cash Flow per Share |
(0.27) | (0.47) | (2.48) | (5.04) | |
Free Cash Flow |
(24.79) | (27.76) | (20.66) | (30.65) | |
Capital Expenditures |
(1.75) | (3.06) | (3.89) | (5.28) | |
Piotroski F-Score |
3.00 | 3.00 | 1.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(23.93%) | (22.46%) | (28.38%) | (15.00%) | |
Accounts Receivable Turnover |
3.96 | 5.38 | 2.86 | 2.79 | |
Accounts Payable Turnover |
7.61 | 8.86 | 6.60 | 5.44 | |
Inventory Turnover |
2.25 | 2.11 | 2.11 | 1.94 | |
Average Days of Payables |
26.15 | 32.47 | 59.35 | 66.95 | |
Days of Inventory on Hand |
112.65 | 143.59 | 174.17 | 204.91 | |
Tax Rate |
0.02 | 0.02 | 0.02 | 0.00 | |
Research and Development Expense of Revenue |
16.60% | 14.84% | 16.94% | 17.70% | |
Selling, General and Administrative Expense of Revenue |
58.99% | 53.72% | 59.62% | 45.44% | |
Share Based Compensation of Revenue |
0.66% | 0.67% | 1.66% | 1.90% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.25 | 0.27 | 0.14 | 0.54 | |
Depreciation/Fixed assets |
0.52 | 0.75 | 0.89 | 0.15 | |
Capex/Depreciation |
(0.21) | (0.26) | (0.27) | (0.36) | |
Revenue per Share |
0.50 | 0.85 | 5.45 | 8.44 | |
Operating CF per Share |
(0.25) | (0.42) | (2.02) | (4.17) | |
Capex per Share |
(0.02) | (0.05) | (0.47) | (0.87) | |
Capex to Sales |
0.04 | 0.06 | 0.09 | 0.10 | |
Net Profit Margin |
(197.78%) | (188.14%) | (269.31%) | (91.50%) |
Columns are period end dates